Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model
Michael Patrick Lux, M. Hartmann, C. Jackisch, G. Raab, A. Schneeweiß, K. Possinger, J. Oyee, N. HarbeckVolume:
117
Language:
english
Pages:
13
DOI:
10.1007/s10549-008-0294-9
Date:
September, 2009
File:
PDF, 849 KB
english, 2009